ImmunityBio
IBRX
IBRX
260 hedge funds and large institutions have $352M invested in ImmunityBio in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 91 increasing their positions, 57 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $328M → $352M (+$24.1M)
1.07% more ownership
Funds ownership: 14.06% → 15.14% (+1.1%)
6% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $12.4M
Holders
260
Holding in Top 10
2
Calls
$11.7M
Puts
$12.4M
Top Buyers
| 1 | +$16.2M | |
| 2 | +$14.4M | |
| 3 | +$12.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.1M |
| 5 |
BlackRock
New York
|
+$5.03M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$17.5M | |
| 3 | -$7.86M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$883K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$848K |
